Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Pernille Koefoed-Nielsen"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Acute mixed cellular and antibody-mediated rejection (MR) has an estimated prevalence of 7.8%. However, knowledge of MR immune pathogenesis in cardiac graft rejection remains sparse. We report a case of acute MR in a heart transplant patient with a m
Externí odkaz:
https://doaj.org/article/47e51177c3014d9f98b7458b79f00b4f
Autor:
Maja Nørgaard, Liselotte Stenkjær, Marie Quach Lam, Ida Schwartz Bobach, Pernille Koefoed‐Nielsen
Publikováno v:
HLA. 101:683-685
Autor:
Maja Nørgaard, Liselotte Stenkjær, Katrine Lykke Pedersen, Nicklas Heine Staunstrup, Pernille Koefoed‐Nielsen
Publikováno v:
Nørgaard, M, Stenkjær, L, Pedersen, K L, Staunstrup, N H & Koefoed-Nielsen, P 2023, ' Identification of the novel HLA class I allele, HLA-A*31:215, identified by Next Generation Sequencing ', HLA, vol. 101, no. 5, pp. 533-535 . https://doi.org/10.1111/tan.14943
The novel HLA allele HLA-A*31:215 differs from HLA-A*31:01:02:01 by one nucleotide substitution c.G832A in exon 4. This article is protected by copyright. All rights reserved.
Autor:
Ilse Weinreich, Mats Bengtsson, Jouni Lauronen, Christian Naper, Kaie Lokk, Ilkka Helanterä, Margrét Birna Andrésdóttir, Søren Schwartz Sørensen, Lars Wennberg, Anna Varberg Reisæter, Bjarne Møller, Pernille Koefoed-Nielsen
Publikováno v:
Weinreich, I, Bengtsson, M, Lauronen, J, Naper, C, Lokk, K, Helanterä, I, Andrésdóttir, M B, Sørensen, S S, Wennberg, L, Reisaeter, A V, Møller, B & Koefoed-Nielsen, P 2022, ' Scandiatransplant acceptable mismatch program-10 years with an effective strategy for transplanting highly sensitized patients ', American Journal of Transplantation, vol. 22, no. 12, pp. 2869-2879 . https://doi.org/10.1111/ajt.17182
Weinreich, I, Bengtsson, M, Lauronen, J, Naper, C, Lokk, K, Helanterä, I, Andrésdóttir, M B, Sørensen, S S, Wennberg, L, Reisæter, A V, Møller, B & Koefoed-Nielsen, P 2022, ' Scandiatransplant acceptable mismatch program—10 years with an effective strategy for transplanting highly sensitized patients ', American Journal of Transplantation, vol. 22, no. 12, pp. 2869-2879 . https://doi.org/10.1111/ajt.17182
Weinreich, I, Bengtsson, M, Lauronen, J, Naper, C, Lokk, K, Helanterä, I, Andrésdóttir, M B, Sørensen, S S, Wennberg, L, Reisæter, A V, Møller, B & Koefoed-Nielsen, P 2022, ' Scandiatransplant acceptable mismatch program—10 years with an effective strategy for transplanting highly sensitized patients ', American Journal of Transplantation, vol. 22, no. 12, pp. 2869-2879 . https://doi.org/10.1111/ajt.17182
In March 2009, the Scandiatransplant acceptable mismatch program (STAMP) was introduced as a strategy toward improving kidney allocation to highly sensitized patients. Patients with a transplantability score ≤ 2% are potential candidates for the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8bae2e2efc070136ecc3dba03d10494
http://hdl.handle.net/10138/354246
http://hdl.handle.net/10138/354246
Autor:
Mira Marie Laustsen, Maja Nørgaard, Marie Quach Lam, Pernille Koefoed‐Nielsen, Nicklas Heine Staunstrup
Publikováno v:
Laustsen, M M, Nørgaard, M, Lam, M Q, Koefoed-Nielsen, P & Staunstrup, N H 2022, ' The novel HLA class I allele, HLA-B*14:110, identified by next-generation sequencing ', HLA, vol. 100, no. 5, pp. 520-522 . https://doi.org/10.1111/tan.14721
The novel HLA-allele B*14:110, differs from B*14:02:01:01, by one nucleotide substitution, c.T247A in exon 2.
Autor:
Nørgaard, Maja1 (AUTHOR) majnoe@rm.dk, Stenkjær, Liselotte1 (AUTHOR), Pedersen, Katrine Lykke1 (AUTHOR), Staunstrup, Nicklas Heine1,2 (AUTHOR), Koefoed‐Nielsen, Pernille1 (AUTHOR)
Publikováno v:
HLA: Immune Response Genetics. May2023, Vol. 101 Issue 5, p533-535. 3p.
Autor:
Pernille Koefoed-Nielsen, Maja Nørgaard, Mette Christiansen, Mie Topholm Bruun, Randi K. Berg
Publikováno v:
Berg, R, Nørgaard, M, Bruun, M T, Christiansen, M & Koefoed-Nielsen, P 2020, ' Detecting mismatched donor HLA types from allograft biopsies – An easily applicable tool for improved individualized risk assessment ', Human Immunology, vol. 81, no. 7, pp. 337-341 . https://doi.org/10.1016/j.humimm.2020.04.006
Berg, R, Nørgaard, M, Bruun, M T, Christiansen, M & Koefoed-Nielsen, P 2020, ' Detecting mismatched donor HLA types from allograft biopsies : An easily applicable tool for improved individualized risk assessment ', Human Immunology, vol. 81, no. 7, pp. 337-341 . https://doi.org/10.1016/j.humimm.2020.04.006
Berg, R, Nørgaard, M, Bruun, M T, Christiansen, M & Koefoed-Nielsen, P 2020, ' Detecting mismatched donor HLA types from allograft biopsies : An easily applicable tool for improved individualized risk assessment ', Human Immunology, vol. 81, no. 7, pp. 337-341 . https://doi.org/10.1016/j.humimm.2020.04.006
Short-term allograft survival has improved among solid organ transplant (SOT) patients. An increasing number of SOT patients are prepared for re-transplantation because of chronic allograft failure. Lack of HLA typing or incomplete HLA typing of prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199f2c9ccecc40830709da003a652430
https://portal.findresearcher.sdu.dk/da/publications/8614fb66-ac26-4d11-9de3-ba09b07d46a3
https://portal.findresearcher.sdu.dk/da/publications/8614fb66-ac26-4d11-9de3-ba09b07d46a3
Autor:
Laustsen, Mira Marie1 (AUTHOR), Nørgaard, Maja1 (AUTHOR), Lam, Marie Quach1 (AUTHOR), Koefoed‐Nielsen, Pernille1 (AUTHOR), Staunstrup, Nicklas Heine1,2 (AUTHOR) nickst@rm.dk
Publikováno v:
HLA: Immune Response Genetics. Nov2022, Vol. 100 Issue 5, p520-522. 3p.
Publikováno v:
Koefoed-Nielsen, P & Møller, B K 2019, ' Donor-specific anti-HLA antibodies by solid phase immunoassays : advantages and technical concerns ', International Reviews of Immunology, vol. 38, no. 3, pp. 95-105 . https://doi.org/10.1080/08830185.2018.1525367
The detection of donor-specific antibodies (DSAs) is a cornerstone in the immunological risk assessment prior to organ transplantation. The detection methods have developed rapidly during the last decade, and the evidence for clinical interpretation
Publikováno v:
Journal of Clinical Apheresis. 32:163-169
Transplanting immunized patients requires immunological monitoring in the pretransplant phase to follow reduction of donor specific HLA antibodies (DSA) after Staphylococcus aureus protein A (SPA) immunoadsorption (IA) or therapeutic plasma exchange